Market Trends of Global Cell Culture Industry
This section covers the major market trends shaping the Cell Culture Market according to our research experts:
Drug Development Segment is Expected to Witness Rapid Growth Over the Forecast Period.
Cell culture is an integral part of medical research and drug discovery. Drug development is a time-consuming and costly procedure that is completed in multiple stages, from target identification to lead discovery and optimization, preclinical validation, and clinical trials, culminating in approval for clinical use. Cell-based high throughput screening (HTS) is currently being carried out on cultured cells propagated in two dimensions (2D) on plastic surfaces optimized for tissue culture. With the emergence of 3D cell culture, the process of HTS has become easier and more accurate.
Furthermore, the support from the governments of different countries for drug discovery is also contributing to the growth of the segment. For instance, in July 2020, the Union Government of India launched the Drug Discovery Hackathon "Nishank". This Hackathon is a first-of-its-kind national initiative for supporting the drug discovery process and is supported by various departments as well as market players.
Additionally, the initiatives taken by the market players are also expected to boost the growth of the market segment. For instance, in November 2021, Merck signed a Memorandum of Understanding (MoU) with GI Innovation, to facilitate biomedicine development in Korea. As per the MoU, Merck provides technologies and services, including the CHOZN platform, cell culture media, and downstream process development, to promote research and development of critical life-saving cancer treatments, as well as drugs for allergy-related conditions. Such initiatives also contribute to the growth of the segment.
Thus, owing to the abovementioned factors, the market segment is expected to project significant growth over the forecast period.
North America Dominates the Global Cell Culture Market Over the Forecast Period
North America is currently dominating the cell culture market and is expected to follow the same trend over the forecast period. This is majorly attributed to the growing demand for personalized medicine coupled with the rise in the demand for vaccines, biopharmaceuticals, and artificial organs, and the presence of key players in the market.
According to the American Cancer Society's 2022 statistics, there will be an estimated 1,918,030 new cases of cancer in the United States in 2022. Such an increasing burden of diseases such as cancer creates the need for precision medicine, which leads to the increase in demand for cell culture products and consumables for their development and hence drives the growth of the market.
The launch of products by the market players is also expected to drive the growth of the market. For instance, in December 2020, eNuvio Canada launched one of the first completely reusable 3D cell culture microplates, namely the EB-Plate. Such launches are expected to propel the growth of the market in the region. Additionally, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. The launch of such products and services by the companies also boosts the demand for cell culture products and consumables and is thus expected to drive the growth of the market.
Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show considerable growth over the forecast period.
